Follow Play Earnings CallPlay Earnings Call Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Regulatory Update and Interim Phase 1/2 Data Update for LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy Call Transcript Company Participants Louis Tamayo – CFO & Principal Accounting OfficerR. Townsend – CEO & DirectorSandi Tai – Chief Development OfficerEric Adler – Chief Medical Officer & […]